Chapters

Transcript

Video

Stem Cell Transplant Beneficial for Older Patients with Myelodysplastic Syndrome

New research shows stem cell transplant represents the best therapeutic approach for older individuals with myelodysplastic syndrome. Dana-Farber Cancer Institute's Corey Cutler, MD, MPH, FRCPC explains more.

Read Related Article>>


Published

September 28, 2021

Created by

Dana-Farber

Related Presenters

Corey Cutler, MD, MPH, FRCPC

Corey Cutler, MD, MPH, FRCPC

Medical Director, Adult Stem Cell Transplantation Program

View full profile